Current Applications of Colorectal Cancer Organoids: A Review.

Area of Science:

• Oncology
• Biotechnology
• Translational Medicine

Background:

• Colorectal cancer (CRC) presents significant challenges, particularly in advanced and metastatic stages, characterized by poor prognoses and frequent recurrence.
• The inherent heterogeneity of CRC necessitates personalized treatment approaches to improve patient outcomes.
• Current therapeutic strategies often fall short due to the complex nature of the disease.

Purpose of the Study:

• To provide a comprehensive overview of colorectal cancer (CRC) organoids as a cutting-edge research tool.
• To explore the diverse applications of CRC organoids in scientific research, disease modeling, and drug development.
• To discuss the potential of CRC organoids in advancing personalized medicine strategies for colorectal cancer patients.

Main Methods:

• Review of existing literature on colorectal cancer organoid technology.
• Analysis of the biological relevance and fidelity of organoid models compared to patient tumors.
• Examination of case studies and research findings utilizing CRC organoids for drug screening and therapeutic development.

Main Results:

• Colorectal cancer organoids accurately recapitulate key aspects of primary tumorpathology and heterogeneity.
• Organoids serve as effective platforms for high-throughput drug screening, identifying potential therapeutic candidates.
• The use of organoids facilitates the development of personalized treatment strategies tailored to individual patient profiles.

Conclusions:

• Colorectal cancer organoids represent a significant advancement in preclinical research and disease modeling.
• Organoid technology holds immense potential for accelerating the discovery of novel targeted therapies for CRC.
• The integration of organoids into clinical practice promises to revolutionize personalized medicine for colorectal cancer management.